StyX Holding ApS: Financial statements 2025
CVR: 44292394
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
StyX Holding ApS (CVR 44292394) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -362,255 and a net result of DKK -700,713. Equity in the 2025 report amounted to DKK -354,792.
- Gross Profit
- DKK -362,255
- Profit/Loss
- DKK -700,713
- Equity
- DKK -354,792
- Total Assets
- DKK 2,166,688
- Employees
- 0
Official annual report
How creditworthy is StyX Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
StyX Holding ApS has published its interim report for the period September 8, 2023 to December 31, 2024.
About StyX Holding ApS
StyX Holding ApS is a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Carsten Leonhard Knudsen. The company is owned by Vave Pharma Production ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -362,255 and a net result of DKK -700,713. Equity in the 2025 report amounted to DKK -354,792.